Results 51 to 60 of about 1,825 (197)

Bioequivalence evaluation of new microparticulate capsule and marketed tablet dosage forms of lornoxicam in healthy volunteers [PDF]

open access: yes, 2016
Purpose: To compare oral bioavailability and pharmacokinetic parameters of different lornoxicam formulations and to assess similarity in plasma level profiles by statistical techniques.Methods: An open-label, two-period crossover trial was followed in 24
Ahsan, Muhammad   +5 more
core   +1 more source

French‐Speaking Network of Pharmacogenetics (RNPGx) Recommendations for Gene Panel Analysis Through Genotyping or Sequencing in Pharmacogenetics

open access: yesFundamental &Clinical Pharmacology, Volume 40, Issue 1, January 2026.
ABSTRACT Background The implementation of pharmacogenetics in clinical practice increasingly relies on multigene panels. Objectives The objective of this study is to develop harmonized recommendations for the design and analytical implementation of multigene pharmacogenetic panels, defining clinically relevant genes and associated regions of interest ...
Nicolas Picard   +29 more
wiley   +1 more source

Intoxication by Lornoxicam in Two Dogs

open access: yesActa Scientiae Veterinariae, 2016
Background: The indiscriminate use of drugs is routinely observed in the field of veterinary medicine. Nonsteroidal antiinflammatory drugs (NSAIDs) are the class of drugs that most commonly cause intoxication in pet animals. Lornoxicam, an NSAID, is a cyclooxygenase COX-1 and COX-2 inhibitor and is only recommended for human treatment.
Albuquerque, Alice Ribeiro Oliveira Lima   +3 more
openaire   +3 more sources

Biopolymer‐Based Encapsulation Approach: The Effect of Sea Buckthorn (Hippophae rhamnoides L.) Oil Carried by Chitosan on Fish Fillet Quality

open access: yesJournal of Food Quality, Volume 2026, Issue 1, 2026.
In this study, the effects of chitosan (Ch) coatings encapsulated using an ultrasonic emulsification method with sea buckthorn (Hippophae rhamnoides L.) essential oil (HrEo) on the shelf life and quality parameters of rainbow trout (Oncorhynchus mykiss) fillets, in terms of microbiological, chemical, physical, and sensory properties, were investigated.
Gonca Alak   +13 more
wiley   +1 more source

Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery

open access: yesActa Pharmaceutica, 2015
Solid lipid nanoparticles (SLN), nanostructured lipid carriers (NLC) and nanoemulsion (NE) of lornoxicam (LRX) were prepared for the treatment of painful and inflammatory conditions of the skin.
Gönüllü Ümit   +4 more
doaj   +1 more source

POST-STROKE PAIN SYNDROMES: CLINICAL ASPECTS, DIAGNOSTIC CRITERIA, FEATURES OF THERAPY AND REHABILITATION MEASURES

open access: yesМедицинский совет, 2017
The article is devoted to the topical problem of post-stroke pain syndromes, which are a frequent complication after a stroke. Pain after a stroke is associated with psychoemotional disorders, cognitive dysfunction, dysfunction, impaired quality of life ...
E. V. Kostenko
doaj   +1 more source

ROS‐Responsive Thioketal–Mesoporous Silica Nanoparticles Codelivering Saikosaponin D Suppress Colorectal Cancer Liver Metastasis by Boosting Antitumor Immunity

open access: yesJournal of Nanotechnology, Volume 2026, Issue 1, 2026.
Background Colorectal cancer (CRC) often metastasizes to the liver, which complicates treatment strategies. This study evaluates MSN–TK@SA, a mesoporous silica nanoparticle (MSN) loaded with saikosaponin D (SA) and reactive oxygen species (ROS)–cleaving thioketal (TK), as a targeted approach for CRC metastasis.
Xiaoxia Tang   +9 more
wiley   +1 more source

A pharmacokinetic interaction between cimetidine or ranitidine and lornoxicam [PDF]

open access: yesPostgraduate Medical Journal, 1993
Summary Cimetidine 400 mg twice daily significantly increased serum concentrations and reduced apparent oral clearance of lornoxicam 8 mg twice daily in 12 healthy volunteers. Ranitidine 150 mg twice daily produced no significant changes in lornoxicam pharmacokinetics.
M, Ravic   +5 more
openaire   +2 more sources

Use of Drugs With Actionable Pharmacogenetic Biomarkers and Possible Prescribing Changes Among Older People

open access: yesJournal of the American Geriatrics Society, Volume 73, Issue 12, Page 3679-3689, December 2025.
This graphical abstract illustrates the annual prevalence of exposure to CPIC Level A drugs among older adults, categorized by type of pharmacogenetic recommendation. Data are presented per 1000 older individuals (A) and per 1000 prescriptions (B).
Zinan Zhao   +11 more
wiley   +1 more source

Comparison of lornoxicam versus lornoxicam-gabapentine combination for postoperative analgesia following laparoscopic cholecystectomy

open access: yes, 2012
Preemptif analjezi, nosiseptif afferent ağrı yollarının periferik ve santral sinir sisteminde bloke edilmesi ile santral sensitizasyon ve postoperatif ağrı oluşumunu engellemeyi amaçlar.
Orhan, Gültekin
core   +1 more source

Home - About - Disclaimer - Privacy